HYDERABAD, India, Sept 14 (Reuters) - India's Goa state has warned the local unit of Abbott Laboratories ABT.N it plans to suspend the manufacturing license of its popular antacid medicine after ...

Goa state warns Abbott India on antacid Digene licence suspension India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing licence of its antacid ...

HYDERABAD, India, Sept 14 (Reuters) - India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing licence of its antacid medicine after inspectors flagged ...

Abbott says there is no impact on patient health. The Goa plant is one of Abbott's two factories in India, where Digene has a 7 per cent share of the market for so-called antiflatulent medicines, ...

HYDERABAD, India (Reuters) - India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing licence of its antacid medicine after inspectors flagged ...

The U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, starting August, voluntarily recalled many batches of its Digene Gel ...